Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
2.130
-0.040 (-1.84%)
At close: Dec 19, 2025, 4:00 PM EST
2.160
+0.030 (1.41%)
After-hours: Dec 19, 2025, 6:44 PM EST
Genprex Market Cap
Genprex has a market cap or net worth of $4.94 million as of December 19, 2025. Its market cap has decreased by -45.23% in one year.
Market Cap
4.94M
Enterprise Value
3.84M
1-Year Change
-45.23%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $4.94M, a decrease of -91.94%. That is a compound annual growth rate of -27.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.94M | -31.83% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | 178.67M | 2,798.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |